Predictors of Length of Hospital Stay, Mortality, and Outcomes Among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study.
J Multidiscip Healthc
; 14: 839-852, 2021.
Article
in English
| MEDLINE | ID: covidwho-1197454
ABSTRACT
BACKGROUND:
COVID-19 pandemic is a major strain on health and economic systems, with rapidly increasing demand for in patients' facilities. Disease diagnosis and estimating patients at higher risk is important for the optimal management during the pandemic. This study aimed to identify the predictors of mortality and length of hospital stay in COVID-19 patients.METHODS:
A retrospective cross-sectional study was conducted between March 2020 and August 2020 at Al-Noor Specialist Hospital in Mecca, Saudi Arabia. All patients who were admitted and had a confirmed COVID-19 diagnosis by a real-time polymerase chain reaction (PCR) were included in the study. Descriptive statistics were used to describe patients' demographic characteristics, laboratory findings, and clinical outcomes. Multiple logistic/linear regression analysis was used to identify predictors of death and length of stay at the hospital.RESULTS:
A total of 706 patients were hospitalised for COVID-19. The mean age was 48.0 years (SD 15.6 years). More than half of the patients (68.5%; n= 292) were males. The median duration of stay at the hospital was 6.0 days (IQR 300-1000). The prevalence rate of venous thromboembolism (VTE) among the patients was 3.0% (n= 21). In the multivariate logistic regression analysis, age (AOR 1.05; 1.02-1.09), patients with end-stage renal disease (AOR 6.44; 2.20-18.87), low Oxygen saturation SPO2 (AOR 9.92; 4.19-23.50), D.dimer >0.5 (AOR 13.31; 5.45-32.49), ESR>10 mm/h (AOR 4.08; 1.72-9.68), Ferritin>400mcg/L (AOR 18.55; 6.89-49.96), and Procalcitonin>0.5ug/L (AOR 8.23; 1.81- 37.40) were associated with a higher risk of death among patients with COVID-19. Patients with VTE (AOR 12.86; 3.07- 53.92) were at higher risk of death due to COVID-19.CONCLUSION:
Hospitalised COVID-19 patients have multiple negative consequences in terms of their laboratory findings, signs and symptoms. Age and end-stage renal diseases have a significant impact on the mortality rate and the length of hospital stay among COVID-19 patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
J Multidiscip Healthc
Year:
2021
Document Type:
Article
Affiliation country:
JMDH.S304788
Similar
MEDLINE
...
LILACS
LIS